2012
DOI: 10.1016/j.jconrel.2012.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Cell entry of cell penetrating peptides: tales of tails wagging dogs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
187
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 215 publications
(200 citation statements)
references
References 134 publications
5
187
0
Order By: Relevance
“…Incorporation into the delivery system of new methods to increase the membrane (27,28). CPPs comprise short polycationic peptides based on hydrophobic sequences derived from signal peptides, viral peptides, or other sources (29), and are recognized as promising tools for the intracellular delivery of macromolecular medicines (30)(31)(32)(33). Our recent study has shown that the absorption of insulin and other medicinal peptides and proteins across the epithelial mucosal membrane can be improved significantly by the coadministration of new CPPs with biodrug cargos (13)(14)(15).…”
Section: Discussionmentioning
confidence: 99%
“…Incorporation into the delivery system of new methods to increase the membrane (27,28). CPPs comprise short polycationic peptides based on hydrophobic sequences derived from signal peptides, viral peptides, or other sources (29), and are recognized as promising tools for the intracellular delivery of macromolecular medicines (30)(31)(32)(33). Our recent study has shown that the absorption of insulin and other medicinal peptides and proteins across the epithelial mucosal membrane can be improved significantly by the coadministration of new CPPs with biodrug cargos (13)(14)(15).…”
Section: Discussionmentioning
confidence: 99%
“…These include HIVderived HGP-peptide (Kwon et al 2010), TATfusion peptide (Wadia et al 2004), influenza virus hemagglutinin HA-2 amino-terminal fusogenic peptide (Wagner et al 1992), and papillomavirus L240 peptide (Kwon et al 2008). These natural cell-penetrating peptides have also inspired several synthetic strategies, and several artificial peptides have been proposed to favor cellular delivery (Subbarao et al 1987;Wyman et al 1997;Stayton et al 2000;Jones and Sayers 2012). There is still much unknown about the cell penetration and poration mechanisms of these peptides as well as concerns regarding immunogenicity and cytotoxicity (Jones and Sayers 2012).…”
Section: Endosome Escape Strategiesmentioning
confidence: 99%
“…These natural cell-penetrating peptides have also inspired several synthetic strategies, and several artificial peptides have been proposed to favor cellular delivery (Subbarao et al 1987;Wyman et al 1997;Stayton et al 2000;Jones and Sayers 2012). There is still much unknown about the cell penetration and poration mechanisms of these peptides as well as concerns regarding immunogenicity and cytotoxicity (Jones and Sayers 2012). One way around the intrinsic immunogenicity of pathogen-derived peptides is to design synthetic polymers and lipids that enhance endosomal escape.…”
Section: Endosome Escape Strategiesmentioning
confidence: 99%
“…Potential intracellular drug delivery carriers, such as Tat-derived peptides (93), have also been studied. FRAP was used to investigate the intracellular mobility of Tat-peptides with cargoes of different molecular weights below and above the threshold for diffusion through the nuclear pores (94).…”
Section: Drug Delivery Inside Cellsmentioning
confidence: 99%